Does Wegovy mess with your hormones?

The hormone Wegovy is based on, and what it actually does

GLP-1 stands for glucagon-like peptide-1. Your small intestine releases it every time you eat, and it does several things at once: it signals fullness to the brain, slows the rate at which food leaves your stomach, and nudges the pancreas to release the right amount of insulin in response to a meal. Semaglutide is a synthetic version of GLP-1, engineered to last a week in the body rather than the few minutes the natural version survives. That is the entire mechanism. It targets GLP-1 receptors, and, unlike some other hormones you might be thinking of, those receptors are not clustered in the ovaries, testes, thyroid or adrenal glands.

So when people ask whether Wegovy contains hormones, the honest answer is: it contains a hormone analogue, yes, but one that acts on appetite and digestion, not on your reproductive or endocrine system in any direct way. The STEP 1 trial, published in the New England Journal of Medicine, followed nearly 2,000 adults over 68 weeks and did not flag disruption to sex hormones or thyroid function as a finding. What it did find was an average weight reduction of around 15%, and weight loss at that scale has its own downstream hormonal consequences, which is where things get more nuanced.

If you want a more detailed breakdown of the specific hormone pathway involved, our page on what hormone is in Wegovy covers the GLP-1 mechanism in full.

The hormonal effects that do appear, and why they happen

Adipose tissue (body fat) is not just stored energy. It is metabolically active: it produces oestrogen, leptin, adiponectin and inflammatory cytokines. When someone loses a significant amount of weight, those outputs change. Women may notice shifts in their cycle (periods becoming lighter, heavier, more or less regular) not because semaglutide has tampered with their ovaries, but because the hormonal environment around them has shifted as fat mass falls. This is well-recognised in the broader weight-loss literature and is generally not a cause for alarm, though it is worth mentioning to a GP if cycles change noticeably.

Fertility is a related question. Women who previously had irregular cycles because of obesity-related hormone imbalance sometimes find their cycles regularise on treatment, and with that, fertility may increase. Anyone who is not trying to conceive should use reliable contraception. For a fuller look at how semaglutide interacts with the menstrual cycle specifically, our page on semaglutide and periods goes into the detail. And if your question is specifically about the pill, our page on Wegovy and birth control covers what current guidance says, including why the advice differs slightly from that given for tirzepatide (Mounjaro).

One important clarification on contraception: NHS England's guidance on weight-management injections notes that, unlike tirzepatide, there is no equivalent evidence that semaglutide reduces oral contraceptive absorption. That said, your prescriber is the right person to review your contraception choices before starting any weight-loss medicine.

What the clinical evidence does not show, the hormones Wegovy does not touch

There is no robust clinical evidence that therapeutic semaglutide doses affect thyroid hormone levels in people without pre-existing thyroid disease. The prescribing information does carry a precaution about medullary thyroid carcinoma (a rare tumour type) based on animal studies at high doses, but this is a contraindication for people with a personal or family history of MTC or MEN2, not a warning that the drug causes thyroid disruption in the general population. Oestrogen and testosterone levels are not known to be directly altered by semaglutide either.

Cortisol is another hormone that sometimes comes up in this conversation. Chronic excess cortisol (as in Cushing's syndrome) causes weight gain, so people sometimes wonder whether a weight-loss drug works by suppressing cortisol. It does not. Semaglutide has no known direct action on the adrenal axis. The weight comes off because appetite falls and food intake reduces, not because of any stress-hormone effect.

For a broader look at how semaglutide relates to your hormonal health, the page on whether semaglutide affects hormones covers additional angles, including insulin and glucagon, in more depth. You can also find general information about how Wegovy works as a treatment on our main Wegovy page.

Practical points if hormone-related questions are part of your decision

If you are weighing up treatment and hormonal health is a real concern (perhaps you have PCOS, a thyroid condition, are perimenopausal, or are thinking about pregnancy in the next year or two) those are exactly the conversations to have during a clinical consultation, not something to resolve by reading a single page online. A prescriber needs to see the full picture.

Wegovy is not recommended during pregnancy, while breastfeeding, or for anyone actively trying to conceive. It is also not licensed for under-18s. If you are considering coming off treatment to try for a baby, your prescriber will advise on the appropriate wash-out period before conception. These are not edge-case questions; our prescribers hear them regularly.

On the practical side: if you are thinking about starting and wondering about costs, our Wegovy pricing page explains what private treatment typically includes, so there are no surprises. When you are ready to talk through your own situation (including any hormone-related history) you can start a free consultation with our team. A named GPhC-registered prescriber reads every form the same day it is submitted. No algorithm makes the call.